Кутивейт

Кутивейт – the outside glucocorticosteroid drug used at treatment of a dermatosis.

Form of release and structure

Кутивейт release in the following dosage forms:

• Ointment for external use: translucent, homogeneous, almost white or white color (on 15 g in aluminum tubas, on 1 tuba in a cardboard pack);
External
• use cream: soft, homogeneous, almost white or white color (on 15 g in aluminum tubas, on 1 tuba in a cardboard pack).

Is a part of 1000 mg of ointment:

• Active agent: propionate of a flutikazon – 0,05 mg (0,005%);
• Auxiliary components: microcrystallic wax – 25%, propylene glycol – 5%, sorbitan sesquioleate – 0,5%, liquid paraffin – to 100%.

Is a part of 1000 mg of cream:

• Active agent: propionate of a flutikazon – 0,5 mg (0,05%);
• Auxiliary components: isopropyl myristate – 5%, liquid paraffin – 40%, a ketomacrogoal of 1000 - 0,75%, cetostearyl alcohol – 5,25%, propylene glycol – 10%, sodium phosphate – 0,15%, imidourea – 0,2%, monohydrate of citric acid – 0,05%, the purified water – to 100%.

Indications to use

Кутивейт appoint for treatment of a dermatosis (acute and chronic):

• Eczema;
• Diskoidny lupus erythematosus;
• Dermatitis (atopic, contact, seborrheal);
• Red flat deprive;
• Neurodermatoses, including idle time deprive;
• Psoriasis;
• Erythrosis (as an additional tool to system therapy by glucocorticosteroids);
• Stings of insects.

Also drug is used for decrease in risk of emergence of a recurrence of the atopic eczema proceeding in a chronic form, in cases of existence of therapeutic effect at treatment of an acute phase of a disease.

Contraindications

• Pink eels;
• Perioral dermatitis;
• Ordinary eels;
• Fungal and viral infections of skin;
• Genital and perianal itch;
• Age up to 6 months (for ointment), till 1 year (for cream);
• Hypersensitivity to drug components.

The feeding and pregnant women of Kutiveyt need to apply with care.

Route of administration and dosage

Кутивейт apply outwardly.

At treatment of a dermatosis (acute and chronic) cream or ointment a thin layer are applied on an affected area of skin. Frequency rate of use – 1-2 times a day, therapy duration – 14 days.

At Kutiveyt's use for decrease in risk of emergence of palindromias after successful treatment of an acute phase frequency rate of use of means is reduced: single putting cream or ointment 2 times a week without imposing of an occlusive bandage is recommended.

Кутивейт it is necessary to apply on all earlier struck skin sites or on sites where manifestation of a palindromia is possible.

Side effects

At Kutiveyt's use there can be following side effects:

• Local reactions: an itch and burning in a drug site of application (at development of symptoms of reaction of hypersensitivity therapy needs to be stopped immediately), atrophic skin changes (a hypertrichosis, striya, thinning of skin, expansion of superficial blood vessels, hypopigmentation), an aggravation of signs of a dermatosis, development of allergic contact dermatitis; sometimes – emergence of consecutive infections (especially when using occlusive bandages and when drawing Kutiveyt's on area of skin folds);
• System reactions: at long use in high doses or when drawing Kutiveyta on extensive sites of skin is possible considerable system absorption of drug with development of a symptomatic hypercorticoidism. Most often it is observed at children of early and younger age, and also at use of occlusive bandages (at children diapers and diapers can perform their function). In rare instances use or cancellation of glucocorticosteroids at treatment of psoriasis can provoke emergence of a pustular form of a disease.

Special instructions

Long therapy in high doses on extensive body parts, especially at children of early and younger age, can lead to suppression of function of bark of adrenal glands.

At external use at children glucocorticosteroids can be absorbed in rather large number therefore children are subject to system influence of drug more, than adults. In this regard Kutiveyt at children is recommended to be applied in the smallest doses providing therapeutic effect.

At treatment of such diseases as a diskoidny lupus erythematosus, psoriasis and heavy eczema it is necessary to consider that atrophic changes at long external use of strong glucocorticoid drugs arise more often on a face, than on other body parts.

When putting cream or ointment on eyelids it is necessary to avoid hit of means in eyes as it can lead to development of glaucoma or local irritation.

During all course of treatment it is recommended to control a condition of the patient regularly.

At psoriasis of Kutiveyt it is necessary to apply with care as during therapy development of generalized pustular psoriasis is possible, tolerances, local or system toxic effects caused by disturbance of barrier function of skin (therapy needs to be carried out under careful control of a condition of patients).

At development of secondary infection it is necessary to apply the appropriate antibacterial medicines. At emergence of signs of spread of an infection it is necessary to cancel Kutiveyt and to appoint system antibacterial drugs.

In wet and warm conditions (including under occlusive bandages) the risk of development of bacterial infections increases therefore leather every time before imposing of a new bandage needs to be processed carefully antiseptic agents.

Therapy by drug is recommended to be combined using the softening cosmetics.

Medicinal interaction

There are no data on Kutiveyt's interaction with other drugs.

Terms and storage conditions

To store in the place, unavailable to children, at a temperature up to 30 °C.

Period of validity – 2 years.